• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种10价或13价肺炎球菌结合疫苗的儿童在11个月龄加强免疫后的B细胞记忆差异

Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.

作者信息

van Westen Els, Wijmenga-Monsuur Alienke J, van Dijken Harry H, van Gaans-van den Brink Jacqueline A M, Kuipers Betsy, Knol Mirjam J, Berbers Guy A M, Sanders Elisabeth A M, Rots Nynke Y, van Els Cécile A C M

机构信息

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven.

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands.

出版信息

Clin Infect Dis. 2015 Aug 1;61(3):342-9. doi: 10.1093/cid/civ274. Epub 2015 Apr 1.

DOI:10.1093/cid/civ274
PMID:25838290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4503810/
Abstract

BACKGROUND

Both the 10- and 13-valent pneumococcal conjugate vaccines (PCV10 and PCV13) induce immunological memory against Streptococcus pneumoniae infections caused by vaccine serotypes. In addition to comparing serum antibody levels, we investigated frequencies of serotype-specific plasma cells (PCs) and memory B-cells (Bmems) as potential predictors of long-term immunity around the booster vaccination at 11 months of age.

METHODS

Infants were immunized with PCV10 or PCV13 at 2, 3, 4, and 11 months of age. Blood was collected before the 11-month booster or 7-9 days afterward. Serotype-specific immunoglobulin G (IgG) levels were determined in serum samples by multiplex immunoassay. Circulating specific PCs and Bmems against shared serotypes 1, 6B, 7F, and 19F and against PCV13 serotypes 6A and 19A were measured in peripheral blood mononuclear cells by enzyme-linked immunospot assay.

RESULTS

No major differences in IgG levels and PC frequencies between groups were found for the 4 shared serotypes. Notably, PCV13 vaccination resulted in higher frequencies of Bmems than PCV10 vaccination, both before and after the booster dose, for all 4 shared serotypes except for serotype 1 postbooster. For PCV13-specific serotypes 6A and 19A, the IgG levels and frequencies of PCs and Bmems were higher in the PCV13 group, pre- and postbooster, except for PC frequencies prebooster.

CONCLUSIONS

Both PCVs are immunogenic and induce measurable IgG, PC, and Bmem booster responses at 11 months. Compared to PCV10, vaccination with PCV13 was associated with overall similar IgG levels and PC frequencies but with higher Bmem frequencies before and after the 11-month booster. The clinical implications of these results need further follow-up.

CLINICAL TRIALS REGISTRATION

NTR3069.

摘要

背景

10价和13价肺炎球菌结合疫苗(PCV10和PCV13)均可诱导针对疫苗血清型引起的肺炎链球菌感染的免疫记忆。除了比较血清抗体水平外,我们还研究了血清型特异性浆细胞(PC)和记忆B细胞(Bmems)的频率,作为11月龄加强免疫前后长期免疫的潜在预测指标。

方法

婴儿在2、3、4和11月龄时接种PCV10或PCV13。在11月龄加强免疫前或之后7 - 9天采集血液。通过多重免疫测定法测定血清样本中的血清型特异性免疫球蛋白G(IgG)水平。通过酶联免疫斑点测定法在外周血单个核细胞中测量针对共同血清型1、6B、7F和19F以及针对PCV13血清型6A和19A的循环特异性PC和Bmems。

结果

对于4种共同血清型,两组之间的IgG水平和PC频率没有发现主要差异。值得注意的是,对于所有4种共同血清型(加强免疫后血清型1除外),PCV13接种在加强免疫前后均导致Bmems频率高于PCV10接种。对于PCV13特异性血清型6A和19A,PCV13组在加强免疫前后的IgG水平、PC和Bmems频率均较高,但加强免疫前PC频率除外。

结论

两种PCV均具有免疫原性,并在11月龄时诱导可测量的IgG、PC和Bmem加强反应。与PCV10相比,PCV13接种与总体相似的IgG水平和PC频率相关,但在11月龄加强免疫前后Bmem频率更高。这些结果的临床意义需要进一步随访。

临床试验注册

NTR3069。

相似文献

1
Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.接种10价或13价肺炎球菌结合疫苗的儿童在11个月龄加强免疫后的B细胞记忆差异
Clin Infect Dis. 2015 Aug 1;61(3):342-9. doi: 10.1093/cid/civ274. Epub 2015 Apr 1.
2
Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.10价或13价肺炎球菌结合疫苗在荷兰婴儿11个月龄加强免疫前后诱导的免疫原性的直接比较
PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015.
3
Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule.混合婴儿肺炎球菌结合疫苗接种程序中的不同记忆B细胞反应。
Pediatr Infect Dis J. 2017 May;36(5):e130-e135. doi: 10.1097/INF.0000000000001497.
4
Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.越南胡志明市婴幼儿接种 10 价与 13 价肺炎球菌结合疫苗的免疫原性和反应原性:一项随机对照试验。
Lancet Infect Dis. 2019 May;19(5):497-509. doi: 10.1016/S1473-3099(18)30734-5. Epub 2019 Apr 8.
5
Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia.在捷克共和国和斯洛伐克,对已接种10价或13价肺炎球菌结合疫苗的儿童加强接种一剂13价肺炎球菌结合疫苗的免疫原性和安全性。
Vaccine. 2017 Sep 12;35(38):5186-5193. doi: 10.1016/j.vaccine.2017.07.103. Epub 2017 Aug 7.
6
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial.10 价肺炎球菌结合疫苗在冈比亚健康婴儿中按照 2+1 程序接种的免疫原性和安全性:一项单中心、双盲、主动对照、随机、3 期临床试验。
Lancet Infect Dis. 2023 May;23(5):609-620. doi: 10.1016/S1473-3099(22)00734-4. Epub 2023 Jan 10.
7
Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.对3.5岁儿童接种PCV-7或PCV-13后再接种PCV-13加强针的记忆B细胞反应。
Vaccine. 2017 May 9;35(20):2701-2708. doi: 10.1016/j.vaccine.2017.03.079. Epub 2017 Apr 6.
8
Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.在先前已接种4剂7价或13价肺炎球菌结合疫苗的儿童中,13价肺炎球菌结合疫苗的肺炎球菌结合疫苗诱导的抗体持久性、免疫原性及安全性
Pediatr Infect Dis J. 2014 Oct;33(10):1065-76. doi: 10.1097/INF.0000000000000459.
9
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.免疫原性、中耳炎、听力损伤和 13 价或 10 价肺炎球菌结合疫苗加强免疫后 6 个月鼻咽携带率:PREVIX_COMBO 和 PREVIX_BOOST 随机对照研究。
Lancet Infect Dis. 2022 Sep;22(9):1374-1387. doi: 10.1016/S1473-3099(22)00272-9. Epub 2022 Jun 27.
10
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial.南非儿童中一剂与两剂基础免疫序贯加强一剂 10 价或 13 价肺炎球菌结合疫苗的免疫原性比较:一项开放标签、随机、非劣效性试验。
Lancet Infect Dis. 2020 Dec;20(12):1426-1436. doi: 10.1016/S1473-3099(20)30289-9. Epub 2020 Aug 25.

引用本文的文献

1
IMMUNOGENICITY AND IMPACT ON NASOPHARYNGEAL CARRIAGE OF A SINGLE DOSE OF PCV10 GIVEN TO VIETNAMESE CHILDREN AT 18 MONTHS OF AGE.单剂量10价肺炎球菌结合疫苗在18月龄越南儿童中的免疫原性及对鼻咽部携带情况的影响
Lancet Reg Health West Pac. 2021 Sep 20;16:100273. doi: 10.1016/j.lanwpc.2021.100273. eCollection 2021 Nov.
2
Comparison of pneumococcal conjugate vaccine (PCV-13) cellular immune responses after primary and booster doses of vaccine.比较肺炎球菌结合疫苗(PCV-13)在初次和加强剂量疫苗后的细胞免疫应答。
Hum Vaccin Immunother. 2020 Dec 1;16(12):3201-3207. doi: 10.1080/21645515.2020.1753438. Epub 2020 May 13.
3

本文引用的文献

1
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.13 价肺炎球菌结合疫苗的血清型特异性效力和保护相关性:上市后间接队列研究。
Lancet Infect Dis. 2014 Sep;14(9):839-46. doi: 10.1016/S1473-3099(14)70822-9. Epub 2014 Jul 17.
2
Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.婴幼儿期接种乙型流感嗜血杆菌结合疫苗后的长期免疫持久性和 B 细胞记忆及加强免疫反应
Clin Infect Dis. 2014 Apr;58(7):949-59. doi: 10.1093/cid/ciu001. Epub 2014 Jan 7.
3
The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects.
血清型特异性免疫记忆在肺炎球菌疫苗接种中的作用:当前认知与未来展望
Vaccines (Basel). 2019 Jan 29;7(1):13. doi: 10.3390/vaccines7010013.
4
Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine.接种10价或13价肺炎球菌结合疫苗初种系列后血清型特异性IgG抗体水平下降。
Vaccines (Basel). 2018 Dec 11;6(4):82. doi: 10.3390/vaccines6040082.
5
Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.10价或13价肺炎球菌结合疫苗在荷兰婴儿11个月龄加强免疫前后诱导的免疫原性的直接比较
PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015.
6
Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong.马来西亚和香港地区婴儿普遍常规接种肺炎球菌疫苗的成本效益分析。
Hum Vaccin Immunother. 2016;12(2):403-16. doi: 10.1080/21645515.2015.1067351.
7
10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers.10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗(PHiD-CV)可诱导肯尼亚健康幼儿产生记忆B细胞反应。
Clin Exp Immunol. 2015 Aug;181(2):297-305. doi: 10.1111/cei.12637. Epub 2015 Jun 10.
The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.
联合疫苗、地理位置、疫苗产品和其他协变量对肺炎球菌结合疫苗免疫原性的差异影响。
Pediatr Infect Dis J. 2014 Jan;33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S130-9. doi: 10.1097/INF.0000000000000081.
4
The history of pneumococcal conjugate vaccine development: dose selection.肺炎球菌结合疫苗的研发历史:疫苗剂量的选择。
Expert Rev Vaccines. 2013 Dec;12(12):1379-94. doi: 10.1586/14760584.2013.852475.
5
Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes.7 价和 13 价肺炎球菌结合疫苗的免疫原性比较及对交叉反应性血清型功能性抗体的产生。
PLoS One. 2013 Sep 23;8(9):e74906. doi: 10.1371/journal.pone.0074906. eCollection 2013.
6
Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.根据 4 种不同的基础免疫方案在婴儿中接种 13 价肺炎球菌结合疫苗的免疫原性:一项随机临床试验。
JAMA. 2013 Sep 4;310(9):930-7. doi: 10.1001/jama.2013.228052.
7
Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.比较 13 价和 7 价肺炎球菌结合疫苗在降低鼻咽部定植方面的免疫原性和疗效:一项随机、双盲试验。
Clin Infect Dis. 2013 Oct;57(7):952-62. doi: 10.1093/cid/cit428. Epub 2013 Jun 26.
8
The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.在 2、4 和 12 个月龄时接种 MenACWY-CRM₁₉₇疫苗的婴幼儿 B 细胞对初免和加强免疫的反应。
Vaccine. 2013 May 7;31(20):2441-8. doi: 10.1016/j.vaccine.2013.03.036. Epub 2013 Apr 6.
9
Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults.儿童和青年人群接种 MMR 疫苗后的抗体和记忆 B 细胞反应动力学。
Vaccine. 2013 Jan 11;31(4):711-7. doi: 10.1016/j.vaccine.2012.11.031. Epub 2012 Nov 19.
10
Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands.侵袭性肺炎球菌病和 7 价肺炎球菌结合疫苗,荷兰。
Emerg Infect Dis. 2012 Nov;18(11):1729-37. doi: 10.3201/eid1811.120329.